Chiyoda Co., Ltd.
Stock Price Chart
2026/07/10 UpdatedPrice Trend
2026/07/10 UpdatedPrice & Trading Details
2026/07/10 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/07/01Earnings Calendar
Updated 2026/07/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2018/01/09 | ¥38.40 | ¥35.72 | -7.0% |
Shareholder Composition
Updated 2026/07/01Major Holders
Updated 2026/07/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
310.5K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
229.8K | 0.00% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
83.9K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
57.5K | -5.27% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
51.9K | -46.99% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Pacific Stock Index Fd.
|
27.1K | 0.00% |
Dividend History
Updated 2026/07/05| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥27 | -38.6% |
| 2025 | ¥44 | +41.9% |
| 2024 | ¥31 | +10.7% |
| 2023 | ¥28 | -3.4% |
| 2022 | ¥29 | - |
Financial Performance
2026/07/05 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥88,651M | ¥92,119M | ¥93,320M | ¥91,835M |
| Gross Profit | ¥40,357M | ¥42,165M | ¥43,942M | ¥43,744M |
| Operating Income | -¥4,384M | -¥2,228M | ¥1,076M | ¥2,197M |
| Pretax Income | -¥2,981M | -¥2,674M | ¥1,447M | ¥2,007M |
| Net Income | -¥3,980M | -¥2,602M | ¥1,851M | ¥2,923M |
| EPS | -¥112.16 | -¥74.23 | ¥52.68 | ¥83.10 |
| Operating Margin | -4.95% | -2.42% | 1.15% | 2.39% |
| Balance Sheet | ||||
| Total Assets | ¥90,676M | ¥87,214M | ¥84,762M | ¥79,076M |
| Total Equity | ¥53,533M | ¥49,842M | ¥50,798M | ¥52,030M |
| Total Liabilities | ¥37,143M | ¥37,372M | ¥33,964M | ¥27,046M |
| Cash | ¥32,030M | ¥25,898M | ¥26,604M | ¥26,398M |
| Interest-bearing Debt | ¥1,588M | ¥1,174M | ¥1,054M | ¥799M |
| Equity Ratio | 59.04% | 57.15% | 59.93% | 65.80% |
| D/E Ratio | 0.03 | 0.02 | 0.02 | 0.02 |
| Cash Flow | ||||
| Operating CF | -¥3,604M | -¥2,980M | ¥2,986M | ¥2,822M |
| Investing CF | ¥2,578M | -¥2,380M | -¥731M | -¥3,164M |
| Financing CF | -¥3,472M | -¥1,379M | -¥1,287M | -¥1,374M |
| Free CF | -¥4,479M | -¥4,288M | ¥2,105M | ¥1,888M |
| Efficiency | ||||
| ROE | -7.43% | -5.22% | 3.64% | 5.62% |
| ROA | -4.39% | -2.98% | 2.18% | 3.70% |
Latest IR Information
-
Chiyoda Co., Ltd. Q1 Fiscal Year 2027 Financial Summary [Japan GAAP] (Consolidated)
For the first quarter of the fiscal year ending February 2027, consolidated results show net sales of ¥21,582 million (YoY: -1.8%), operating income of ¥945 million (YoY: -34.1%), ordinary income of ¥1,099 million (YoY: -24.5%), and net income attributable to...
Read more -
Notice Regarding the Disposal of Treasure Shares as Restricted Stock Compensation
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥1,000
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Chiyoda Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of shoes in Japan. It is also involved in the purchase and wholesale of shoes; and import of shoes and garments. The company operates stores under SHOE PLAZA, TOKYO SHOES RETAILING CENTER, CHIYODA HAKI-GOKOCHI, Chiyoda, cloverleaf, SPC, VifVif by cloverleaf, COURIPIE, and NATURA brand names. Chiyoda Co., Ltd. was founded in 1936 and is headquartered in Tokyo, Japan.
